SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN

Investigation Overview - Pomerantz LLP is investigating claims on behalf of AstraZeneca investors regarding potential securities fraud or unlawful business practices [2][3] - The investigation involves AstraZeneca and certain officers and/or directors [3] Market Impact - AstraZeneca's ADR price fell $5 16 per ADR or 7 22$66 27 per ADR on November 5 2024 [5] Expanded Investigation - The fraud investigation into AstraZeneca has expanded to include several Chinese government agencies implicating dozens of senior executives at the company [6] Firm Background - Pomerantz LLP is a premier firm in corporate securities and antitrust class litigation with offices in multiple global cities [4] - The firm has a history of recovering multimillion-dollar damages awards for class members [4]